Printed from https://ideas.repec.org/b/spr/sprbok/978-3-319-09075-7.html
My bibliography
Save this book
Optimization of Pharmaceutical R&D Programs and Portfolios
Editor
- Zoran Antonijevic(Cytel Inc.)
Abstract
Individual chapters are listed in the "Chapters" tab
Suggested Citation
DOI: 10.1007/978-3-319-09075-7
Download full text from publisher
To our knowledge, this item is not available for download. To find whether it is available, there are three options:1. Check below whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a search for a similarly titled item that would be available.
Book Chapters
The following chapters of this book are listed in IDEAS- Zoran Antonijevic, 2015. "Need for Optimal Design of Pharmaceutical Programs and Portfolios in Modern Medical Product Development," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 3-16, Springer.
- Frederic (Rick) Sax & Raymond A. Huml & Judith Ng-Cashin, 2015. "Clinical Aspects of Pharmaceutical Portfolio Management," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 19-33, Springer.
- Kraig F. Schulz & Sarah T. Bobulsky & Frank S. David & Nitin R. Patel & Zoran Antonijevic, 2015. "Drug Development and the Cost of Capital," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 35-47, Springer.
- Raymond A. Huml, 2015. "Investment Considerations for Pharmaceutical Product Portfolios," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 49-69, Springer.
- Charles Persinger, 2015. "Challenges of Portfolio Management in Pharmaceutical Development," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 71-80, Springer.
- Zoran Antonijevic & Jim Bolognese & Carl-Fredrik Burman & Christy Chuang-Stein & Chris Jennison & Martin Kimber & Olga Marchenko & Nitin R. Patel & José Pinheiro, 2015. "Impact of Phase 2b Strategies on Optimization of Drug Development Programs," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 83-103, Springer.
- Richard Nixon & Blair Ireland, 2015. "Using Decision Analysis to Support the Design of Clinical Trials Within a Program," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 105-122, Springer.
- Jack Kloeber & Alex Stojanovic & C. Kwon Kim, 2015. "Indication Sequencing for a New Molecular Entity with Multiple Potential Oncology Indications," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 123-139, Springer.
- Cong Chen & Robert A. Beckman & Linda Z. Sun, 2015. "Maximizing Return on Investment in Phase II Proof-of-Concept Trials," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 141-154, Springer.
- Robert A. Beckman & Cong Chen, 2015. "Portfolio Optimization of Therapies and Their Predictive Biomarkers," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 155-180, Springer.
- Nitin R. Patel & Suresh Ankolekar, 2015. "Dynamically Optimizing Budget Allocation for Phase 3 Drug Development Portfolios Incorporating Uncertainty in the Pipeline," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, chapter 0, pages 181-200, Springer.
- Zoran Antonijevic, 2015. "Erratum," Springer Books, in: Zoran Antonijevic (ed.), Optimization of Pharmaceutical R&D Programs and Portfolios, edition 127, pages E1-E1, Springer.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprbok:978-3-319-09075-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.